Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

SOLARA ACTIVE PHARMA SCIENCES LTD.

NSE : SOLARABSE : 541540ISIN CODE : INE624Z01016Industry : Pharmaceuticals & DrugsHouse : Private

BSE481.20-7.95 (-1.63 %)

PREV CLOSE ( ) 489.15

OPEN PRICE ( ) 489.25

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 31696

TODAY'S LOW / HIGH ( )476.10 498.55

52 WK LOW / HIGH ( )264.51 559.39

NSE481.70-6.1 (-1.25 %)

PREV CLOSE( ) 487.80

OPEN PRICE ( ) 489.70

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 481.70 (890)

VOLUME 173319

TODAY'S LOW / HIGH( ) 475.55 500.00

52 WK LOW / HIGH ( )263.55 558.8

Select year

(Rs.in Million)

Particulars

Mar 2023

Mar 2022

Mar 2021

Mar 2020

Mar 2019

Profit Before Tax

-448.20

-911.00

2215.00

1149.10

577.50

Adjustment

1867.90

1809.60

1731.60

1680.30

1482.60

Changes In working Capital

7.40

-3137.90

-2058.40

-164.50

-252.90

Cash Flow after changes in Working Capital

1427.10

-2239.30

1888.20

2664.90

1807.20

Cash Flow from Operating Activities

1562.50

-2420.30

1554.60

2421.50

1663.30

Cash Flow from Investing Activities

-811.40

-2428.50

-1063.00

-3588.10

-1156.90

Cash Flow from Financing Activities

-1127.60

3335.70

924.90

969.80

-233.90

Net Cash Inflow / Outflow

-376.50

-1513.10

1416.50

-196.80

272.50

Opening Cash & Cash Equivalents

463.80

1976.90

560.40

757.20

459.50

Cash & Cash Equivalent on Amalgamation / Take over / Merger

25.20

Cash & Cash Equivalent of Subsidiaries under liquidations

Translation adjustment on reserves / op cash balalces frgn subsidiaries

Effect of Foreign Exchange Fluctuations

Closing Cash & Cash Equivalent

87.30

463.80

1976.90

560.40

757.20